Cohort Study of Long-term Safety of Upadacitinib in the Treatment of Atopic Dermatitis in Denmark and Sweden

ENCePP Seal

This study has been awarded the ENCePP seal

Conflicts of interest of investigators

DoIForm_v1.6_Upa AD PASS_JR

Composition of steering group and observers

EUPAS49230-105777

Data sources

• Data source(s):
  Danish registries (access/analysis)

  National Prescribed Drugs Register / Läkemedelsregistret
• Data source(s), other:
  The Swedish National Patient registe Sweden, The Swedish Cause of Death Register Sweden, The Swedish Cancer Register Sweden, The contagious disease register Sweden
• Data sources (types):
  Disease registry

Use of a Common Data Model (CDM)

• CDM mapping:
  No

Data quality specifications

• Check conformance:
  Unknown
• Check completeness:
  Unknown
• Check stability:
  Unknown
• Check logical consistency:
  Unknown

Data characterisation

• Data characterisation conducted:
  No